Treatment FAQ

what is the incidence for reducing hydroxyurea treatment for cancer overtime

by Dr. Efrain O'Connell Published 3 years ago Updated 2 years ago

Can hydroxyurea cause multiple skin cancers?

The association of multiple cutaneous cancers and long-term use of hydroxyurea is now being recognized. In this article, we describe the development of multiple skin tumors in two patients who were receiving hydroxyurea therapy. These cases illustrate the late onset of subsequent skin cancers despite discontinuation of therapy.

How much hydroxyurea will I receive?

Hydroxyurea may be dissolved in water. The amount of Hydroxyurea that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule.

What is hydroxyurea used for in cancer?

Hydroxyurea 1 Use in Cancer. Chronic myelogenous leukemia that is refractory (does not respond to treatment). ... 2 More About Hydroxyurea. Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug. 3 Clinical Trials Accepting Patients. ...

How does hydroxyurea work in the cell cycle?

It acts specifically on the S-phase of the cell cycle by inhibiting the enzyme ribonucleoside diphosphate reductase, thereby hindering the reductive conversion of ribonucleotides to deoxyribonucleotides … Hydroxyurea (HU) is a simple organic compound currently used as a cancer chemotherapeutic agent.

Can you take hydroxyurea for life?

Actually, adults with sickle cell disease who take hydroxyurea seem to live longer than those who do not. There is no known limit to how long you can be on the medication so you should take it as long as it is working.

How many years can you take hydroxyurea?

Is it safe to take hydroxyurea for many years? Yes. Many people with sickle cell disease have taken hydroxyurea safely for over 20 years. Even young children can take it.

Can hydroxyurea be stopped?

Talk to your doctor about how you are feeling during your treatment. Do not stop taking hydroxyurea without talking to your doctor. Your doctor will probably tell you to take another medication, folic acid (a vitamin), to decrease some of the side effects of this medication. Take this medication exactly as directed.

Can you take hydroxyurea long term?

Long-term use of hydroxyurea can cause skin cancer; cutaneous carcinomas are a severe side effect of hydroxyurea. [14] This condition can occur after several years of treatment with hydroxyurea. Patients on HU treatment need to be monitored and follow up for the long term.

Can hydroxyurea cause liver damage?

The severity of the liver injury linked to hydroxyurea therapy is usually mild and self-limited. It has not been linked to cases of chronic hepatitis or vanishing bile duct syndrome.

Does hydroxyurea affect memory?

Hydroxyurea Improves Spatial Memory and Cognitive Plasticity in Mice and Has a Mild Effect on These Parameters in a Down Syndrome Mouse Model. Down syndrome (DS), a genetic disorder caused by partial or complete triplication of chromosome 21, is the most common genetic cause of intellectual disability.

Does hydroxyurea compromise immune system?

Hydroxyurea can weaken your immune system. Call your doctor at once if you have a fever, chills, body aches, extreme tiredness, shortness of breath, bruising, or unusual bleeding.

Can hydroxyurea cause bone marrow suppression?

At high doses, hydroxyurea can cause suppression of the bone marrow (low blood counts) leading to increased risk of anemia, infections or bleeding. Mild liver and kidney damage have been reported in adult patients taking hydroxyurea for other conditions. This has not occurred in sickle cell patients taking hydroxyurea.

Can I take vitamins with hydroxyurea?

Interactions between your drugs No interactions were found between hydroxyurea and Vitamin C. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Should you take folic acid with hydroxyurea?

Hydroxyurea is not a drug that works immediately after one or two doses. It must be taken every day, along with folic acid, because the body makes new sickle cells every day.

Can you drink alcohol with hydroxyurea?

The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of hydroxyurea. you plan to have children, discuss this with your doctor before being treated with hydroxyurea. Hydroxyurea may damage sperm and may harm the baby if used during pregnancy.

Why do you have to wear gloves with hydroxyurea?

To decrease your chance of touching the medicine: Wear disposable gloves when handling the bottle or medicine.

Is hydroxyurea approved for chemo?

Hydroxyurea is approved to treat: Chronic myelogenous leukemia that is refractory (does not respond to treatment). Squamous cell carcinoma of the head and neck (excluding the lip) that is locally advanced. It is used with chemoradiation. The use of hydroxyurea to treat cancer is approved for the Hydrea brand.

Is hydroxyurea used for cancer?

It is used with chemoradiation. The use of hydroxyurea to treat cancer is approved for the Hydrea brand. Hydroxyurea is also approved to treat sickle cell anemia. This use is approved for the Droxia brand. Hydroxyurea is also being studied in the treatment of other conditions and types of cancer.

Is hydroxyurea an alkylating agent?

This myelosuppressive drug, which is not an alkylating agent, is in wide use for the treatment of essential thrombocythemia and other myeloproliferative disorders. 5 Its advantages include convenience, efficacy in reducing the platelet count, and low level of toxicity. 2 However, hydroxyurea must be taken continuously, and if it is inadvertently stopped an excessive rebound increase in the platelet count may occur. 14

Is hydroxyurea good for thrombocythemia?

In conclusion, we found that hydroxyurea was effective not only in reducing the platelet count in patients with essential thrombocythemia but also in preventing thrombosis. However, particular care should be exercised in prescribing this drug to young patients because the risk of secondary leukemia is not known.

Is hydroxyurea leukemogenic?

It is not known whether hydroxyurea is leukemogenic in patients who do not have a myeloproliferative disease . Murphy et al. 18 emphasized that therapy with alkylating agents increased the risk of acute leukemia in patients with essential thrombocythemia who were initially treated with hydroxyurea.

Precautions

Before starting Hydroxyurea treatment, make sure you tell your doctor about any other medications you are taking (including prescription, over-the-counter, vitamins, herbal remedies, etc.). Do not take aspirin, or products containing aspirin unless your doctor specifically permits this.

Self-Care Tips

Drink at least two to three quarts of fluid every 24 hours, unless you are instructed otherwise.

Monitoring and Testing

You will be checked regularly by your health care professional while you are taking Hydroxyurea, to monitor side effects and check your response to therapy. Periodic blood work to monitor your complete blood count (CBC) as well as the function of other organs (such as your kidneys and liver) will also be ordered by your doctor.

How Hydroxyurea Works

Cancerous tumors are characterized by cell division, which is no longer controlled as it is in normal tissue. "Normal" cells stop dividing when they come into contact with like cells, a mechanism known as contact inhibition. Cancerous cells lose this ability.

What is Hydroxyurea used for?

Hydroxyurea is an antimetabolite medication used in the treatment of chronic myeloid leukemia (CML) and head and neck cancers. Hydroxyurea (Hydrea®, Droxia®) | OncoLink. Follow our blogfor education, inspiration, and support during the COVID-19 pandemic. Español.

How to manage fatigue after cancer treatment?

While on cancer treatment, and for a period after, you may need to adjust your schedule to manage fatigue. Plan times to rest during the day and conserve energy for more important activities.

What is the treatment for tumor lysis?

Treatment can include topical steroid ointments and a delay in your next chemotherapy dose. Tumor Lysis Syndrome:If there are a large amount of tumor cells in your body prior to treatment, you are at risk for tumor lysis syndrome. This happens when the tumor cells die too quickly and their waste overwhelms the body.

Does hydroxyurea kill cancer cells?

Lack of functional DNA prevents the cancer cell from reproducing, which results in death of the cell.

What are the side effects of hydroxyurea?

Check with your doctor immediately if any of the following side effects occur while taking hydroxyurea: More common. Black, tarry stools. blood in the urine or stools. chills. cough. fever. hoarseness. lower back or side pain.

Is hydroxurea carcinogenic?

Monitor blood counts at baseline and throughout treatment. Interrupt treatment and reduce dose as necessary. Hydroxyurea is carcinogenic. Advise sun protection and monitor patients for malignancy.

Does hydroxyurea need medical attention?

Side effects not requiring immediate medical attention. Some side effects of hydroxyurea may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine.

Research

  • Hydroxyurea is approved to treat: 1. Chronic myelogenous leukemia that is refractory (does not respondto treatment). 2. Squamous cell carcinoma of the head and neck (excluding the lip) that is locally advanced. It is used with chemoradiation. The use of hydroxyurea to treat cancer is approved for the Hydrea brand. Hydroxyurea is also approved to tr...
See more on cancer.gov

Trial

Administration

Risks

Image
We conducted a prospective, randomized trial to assess whether hydroxyurea, given to keep the platelet count below 600,000 per cubic millimeter, reduces the incidence of thrombosis in patients with essential thrombocythemia who are at high risk for thrombotic complications. This study was not designed to assess th…
See more on nejm.org

Diagnosis

  • In a cohort of 198 patients seen at our two institutions who were given a diagnosis of essential thrombocythemia according to previously reported criteria,3 114 patients (57.6 percent) were eligible for the present trial because they were more than 60 years of age (62 patients), had had a previous thrombosis (17 patients), or met both criteria (35 patients), and had a platelet count of …
See more on nejm.org

Applications

  • Between April 1990 and August 1993, 56 patients were randomly assigned to hydroxyurea treatment and 58 patients were randomly assigned to the control group (no hydroxyurea treatment). The treated patients were seen every two weeks until the platelet count was below 600,000 per cubic millimeter, and at least every two months thereafter. The 58 control patients …
See more on nejm.org

Side effects

  • Information concerning five major risk factors for vascular disease (hypertension, cigarette smoking, diabetes mellitus, hyperlipidemia, and previous thrombotic events), defined as previously reported,3 was recorded with use of a standard questionnaire.
See more on nejm.org

Performance

  • We classified bleeding as major8 if it required hospitalization or blood transfusion. All other episodes of bleeding were classified as minor (grade 1 to 2 according to World Health Organization criteria).9
See more on nejm.org

Adverse effects

  • The rates of thrombotic complications in the two groups of patients were compared by the chi-square test with Yates' correction; 95 percent confidence limits for the difference in the rates of thrombosis were calculated according to the method of Gardner and Altman.10 The KaplanMeier method was used to construct curves for thrombosis-free survival.11 The log-rank statistic was …
See more on nejm.org

Uses

  • In all patients in the hydroxyurea group, treatment with the drug resulted in a decrease in the platelet count to below 600,000 per cubic millimeter (median count, 459,000 per cubic millimeter; range, 285,000 to 628,000 per cubic millimeter) after a median of 30 days (range, 16 to 60). The response continued with long-term therapy, and there was no need for frequent adjustments of t…
See more on nejm.org

Results

  • In the control group, the platelet count ranged from 892,000 to 986,000 per cubic millimeter at six months (Figure 1). No single platelet count exceeded 1,500,000 per cubic millimeter during follow-up. If such a count had been recorded, the patient would have been removed from the control group.
See more on nejm.org

Prognosis

  • Ten of 16 patients with thrombosis (62.5 percent) 2 in the hydroxyurea group and 8 in the control group had been taking aspirin (n = 6) or ticlopidine (n = 4) before thrombosis occurred, as compared with 69 of 98 asymptomatic patients (70 percent). Multivariate analysis did not reveal a significant effect of antiplatelet drugs on the outcome. Smoking status was the only variable oth…
See more on nejm.org

Contraindications

  • This prospective, randomized trial demonstrates the usefulness of hydroxyurea in preventing thrombosis in high-risk patients with essential thrombocythemia. This myelosuppressive drug, which is not an alkylating agent, is in wide use for the treatment of essential thrombocythemia and other myeloproliferative disorders.5 Its advantages include convenience, efficacy in reducin…
See more on nejm.org

Safety

  • In our study, 2 of the 56 patients treated with hydroxyurea had thrombotic episodes (stroke in a 71-year-old woman and myocardial infarction in a 76-year-old man) during the 27-month follow-up period. By contrast, there were 14 vascular occlusive events in the 58 untreated controls. In all patients randomly assigned to hydroxyurea treatment, the platelet count decreased below 600,0…
See more on nejm.org

Treatment

  • As in previous studies of essential thrombocythemia3,4 the most frequent thrombotic complications in high-risk patients involved the central nervous system and peripheral and coronary arteries. Hemorrhagic complications occurred in only five patients (4.4 percent), and these patients were all taking aspirin or ticlopidine prophylactically, indicating once again that th…
See more on nejm.org

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9